EGR2 and neoplasm: We found that CX3CR1+ macrophages enhanced the expression of the corresponding target tumor inhibitory genes, such as BTG2, EGR2, ERG3, NR0B1, and SDC4, on NR5A1+ tumor cells (Fig. 6A).